Literature DB >> 20334075

Central retinal vein occlusion in young women: rare cases with oral contraceptive pills as a risk factor.

R Thapa1, G Paudyal.   

Abstract

Central retinal vein occlusion in young people is a rare entity. Here we present two cases of central retinal vein occlusion in young women using oral contraceptive pills. We found no other systemic problems and all routine investigations were within normal limits. The cases were managed with further avoidance of oral contraceptives and intravitreal injections of Bevacizumab (Avastin) to reduce the macular edema.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20334075

Source DB:  PubMed          Journal:  Nepal Med Coll J        ISSN: 2676-1319


  6 in total

1.  Acute central retinal vein occlusion following episode of myopericarditis in an adolescent patient.

Authors:  Ankit Desai; Sandeep Saxena; Levent Akduman
Journal:  BMJ Case Rep       Date:  2013-08-01

2.  A longitudinal analysis of risk factors associated with central retinal vein occlusion.

Authors:  Maxwell S Stem; Nidhi Talwar; Grant M Comer; Joshua D Stein
Journal:  Ophthalmology       Date:  2012-11-20       Impact factor: 12.079

3.  Intense exercise causing central retinal vein occlusion in a young patient: case report and review of the literature.

Authors:  Elad Moisseiev; Oded Sagiv; Moshe Lazar
Journal:  Case Rep Ophthalmol       Date:  2014-04-05

4.  Etiological factors in young patients with Retinal Vein Occlusion.

Authors:  Serhad Nalcaci; Cumali Degirmenci; Cezmi Akkin; Jale Mentes
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

5.  Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients.

Authors:  Rohina S Aggarwal; Vineet V Mishra; Somesh V Aggarwal
Journal:  J Hum Reprod Sci       Date:  2013-01

Review 6.  Gender differences in ocular blood flow.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  Curr Eye Res       Date:  2014-06-03       Impact factor: 2.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.